Clinical Trial Update: A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing plazomicin to colistin in CRE infections completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bloodstream Infections Due to Carbapenem-resistant Enterobacteriaceae
• Complicated Urinary Tract Infection Due to Cre
• Hospital-acquired Bacterial Pneumonia Due to Cre
• Pyelonephritis Due to Cre
• Ventilator-associated Bacterial Pneumonia Due to Cre

Drugs mentioned

• Colistin (colistin)
• Plazomicin (plazomicin)

Snippet

Sponsor: Achaogen, Inc. | Conditions: Bloodstream Infections (BSI) Due to CRE, Hospital-Acquired Bacterial Pneumonia (HABP) Due to CRE | Phase 3 | Status: COMPLETED | Results posted: 2018-10-16